Abstract
The International Mismatch Repair Consortium (IMRC) is a collaboration of clinicians and scientists who have agreed to pool and analyse data on Lynch syndrome, a genetic predisposition to cancer caused by germline mutations in DNA mismatch repair genes or EPCAM deletion, with the rationale that research on this hereditary syndrome will benefit from large datasets from many countries. As of October 2017, the IMRC includes approximately 273 members from 122 centres/clinics in 29 countries throughout Africa, Asia, Australasia, Europe, and North and South America, who are involved in research or treatment of people with Lynch syndrome and their families. To date, there are six research projects registered at the IMRC: cancer risks for Lynch syndrome, classification of mismatch repair variants, genetic testing and screening practices, environmental and lifestyle modifiers of cancer risk, inherited methylation and cancer risks for family members of constitutional mismatch repair deficiency (CMMR-D) patients. The most significant project, in terms of data accrued, is the study of cancer risks for Lynch syndrome which mainly asks whether age-specific cumulative risk (penetrance) of cancers differs by country or geographic region. As of October 2017, almost 6200 pedigrees from investigators from approximately 24 countries have been submitted for penetrance analysis – see http://www.sphinx.org.au/imrc.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dowty JG, Win AK, Buchanan DD, Lindor NM, Macrae FA, Clendenning M, et al. Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013;34(3):490–7. https://doi.org/10.1002/humu.22262.
Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42(6):491–6. https://doi.org/10.1136/jmg.2004.024299.
Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome. JAMA. 2011;305(22):2304–10. https://doi.org/10.1001/jama.2011.743.
Baglietto L, Lindor NM, Dowty JG, White DM, Wagner A, Gomez Garcia EB, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102(3):193–201. https://doi.org/10.1093/jnci/djp473.
Senter L, Clendenning M, Sotamaa K, Hampel H, Green J, Potter JD, et al. The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology. 2008;135(2):419–28.e1. https://doi.org/10.1053/j.gastro.2008.04.026.
Stoffel E, Mukherjee B, Raymond VM, Tayob N, Kastrinos F, Sparr J, et al. Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology. 2009;137(5):1621–7. https://doi.org/10.1053/j.gastro.2009.07.039.
Choi Y-H, Cotterchio M, McKeown-Eyssen G, Neerav M, Bapat B, Boyd K, et al. Penetrance of colorectal cancer among MLH1/ MSH2 carriers participating in the colorectal cancer familial registry in Ontario. Hered Cancer Clin Prac. 2009;7:14. https://doi.org/10.1186/1897-4287-7-14.
Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6(1):105–10.
Hampel H, Stephens JA, Pukkala E, Sankila R, Aaltonen LA, Mecklin JP, et al. Cancer risk in hereditary nonpolyposis colorectal cancer syndrome: later age of onset. Gastroenterology. 2005;129(2):415–21. https://doi.org/10.1016/j.gastro.2005.05.011.
ten Broeke SW, Brohet RM, Tops CM, van der Klift HM, Velthuizen ME, Bernstein I, et al. Lynch syndrome caused by germline PMS2 mutations: delineating the cancer risk. J Clin Oncol. 2015;33(4):319–25. https://doi.org/10.1200/jco.2014.57.8088.
Moller P, Seppala T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, et al. Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database. Gut. 2017;66(3):464–72. https://doi.org/10.1136/gutjnl-2015-309675.
Arnold S, Buchanan DD, Barker M, Jaskowski L, Walsh MD, Birney G, et al. Classifying MLH1 and MSH2 variants using bioinformatic prediction, splicing assays, segregation, and tumor characteristics. Hum Mutat. 2009;30(5):757–70. https://doi.org/10.1002/humu.20936.
Thompson BA, Goldgar DE, Paterson C, Clendenning M, Walters R, Arnold S, et al. A multifactorial likelihood model for MMR gene variant classification incorporating probabilities based on sequence bioinformatics and tumor characteristics: a report from the Colon Cancer Family Registry. Hum Mutat. 2013;34(1):200–9. https://doi.org/10.1002/humu.22213.
Spurdle AB. Clinical relevance of rare germline sequence variants in cancer genes: evolution and application of classification models. Curr Opin Genet Dev. 2010;20(3):315–23. https://doi.org/10.1016/j.gde.2010.03.009.
Lindor N, Peterson G, Spurdle A, Thompson B, Goldgar D, Thibodeau S. Pancreatic cancer and a novel MSH2 germline alteration. Pancreas. 2011;40(7):1138–40. https://doi.org/10.1097/MPA.0b013e318220c217.
Stuckless S, Parfrey PS, Woods MO, Cox J, Fitzgerald GW, Green JS, et al. The phenotypic expression of three MSH2 mutations in large Newfoundland families with Lynch syndrome. Fam Cancer. 2007;6(1):1–12. https://doi.org/10.1007/s10689-006-0014-8.
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–917. https://doi.org/10.1002/ijc.25516.
Le Marchand L. Combined influence of genetic and dietary factors on colorectal cancer incidence in Japanese Americans. J Natl Cancer Inst Monogr. 1999;26:101–5.
Park JG, Park YJ, Wijnen JT, Vasen HF. Gene-environment interaction in hereditary nonpolyposis colorectal cancer with implications for diagnosis and genetic testing. Int J Cancer. 1999;82(4):516–9.
van Vliet CM, Dowty JG, van Vliet JL, Smith L, Mead LJ, Macrae FA, et al. Dependence of colorectal cancer risk on the parent-of-origin of mutations in DNA mismatch repair genes. Hum Mutat. 2011;32(2):207–12. https://doi.org/10.1002/humu.21408.
Green J, O'Driscoll M, Barnes A, Maher ER, Bridge P, Shields K, et al. Impact of gender and parent of origin on the phenotypic expression of hereditary nonpolyposis colorectal cancer in a large Newfoundland kindred with a common MSH2 mutation. Dis Colon Rectum. 2002;45(9):1223–32. https://doi.org/10.1097/01.DCR.0000027034.98952.85.
Jarvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA, Peltomaki P, et al. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000;118(5):829–34.
Parry S, Win AK, Parry B, Macrae FA, Gurrin LC, Church JM, et al. Metachronous colorectal cancer risk for mismatch repair gene mutation carriers: the advantage of more extensive colon surgery. Gut. 2011;60(7):950–7. https://doi.org/10.1136/gut.2010.228056.
Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet. 2011;378(9809):2081–7. https://doi.org/10.1016/S0140-6736(11)61049-0.
Win AK, Dowty JG, English DR, Campbell PT, Young JP, Winship I, et al. Body mass index in early adulthood and colorectal cancer risk for carriers and non-carriers of germline mutations in DNA mismatch repair genes. Br J Cancer. 2011;105(1):162–9. https://doi.org/10.1038/bjc.2011.172.
Botma A, Nagengast FM, Braem MGM, Hendriks JCM, Kleibeuker JH, Vasen HFA, et al. Body mass index increases risk of colorectal adenomas in men with Lynch syndrome: the GEOLynch cohort study. J Clin Oncol. 2010;28(28):4346–53. https://doi.org/10.1200/jco.2010.28.0453.
Watson P, Ashwathnarayan R, Lynch HT, Roy HK. Tobacco use and increased colorectal cancer risk in patients with hereditary nonpolyposis colorectal cancer (Lynch syndrome). Arch Intern Med. 2004;164(22):2429–31. https://doi.org/10.1001/archinte.164.22.2429.
Pande M, Lynch PM, Hopper JL, Jenkins MA, Gallinger S, Haile RW, et al. Smoking and colorectal cancer in Lynch syndrome: results from the Colon Cancer Family Registry and the University of Texas M.D. Anderson Cancer Center. Clin Cancer Res. 2010;16(4):1331–9. https://doi.org/10.1158/1078-0432.ccr-09-1877.
Chau R, Dashti SG, Ait Ouakrim D, Buchanan DD, Clendenning M, Rosty C, et al. Multivitamin, calcium and folic acid supplements and the risk of colorectal cancer in Lynch syndrome. Int J Epidemiol. 2016;45(3):940–53. https://doi.org/10.1093/ije/dyw036.
Dashti SG, Buchanan DD, Jayasekara H, Ait Ouakrim D, Clendenning M, Rosty C, et al. Alcohol consumption and the risk of colorectal cancer for mismatch repair gene mutation carriers. Cancer Epidemiol Biomark Prev. 2017;26(3):366–75. https://doi.org/10.1158/1055-9965.epi-16-0496.
Ferlitsch M, Reinhart K, Pramhas S, Wiener C, Gal O, Bannert C, et al. Sex-specific prevalence of adenomas, advanced adenomas, and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 2011;306(12):1352–8. https://doi.org/10.1001/jama.2011.1362.
Bauer CM, Ray AM, Halstead-Nussloch BA, Dekker RG, Raymond VM, Gruber SB, et al. Hereditary prostate cancer as a feature of Lynch syndrome. Fam Cancer. 2011;10(1):37–42. https://doi.org/10.1007/s10689-010-9388-8.
Grindedal EM, Moller P, Eeles R, Stormorken AT, Bowitz-Lothe IM, Landro SM, et al. Germ-line mutations in mismatch repair genes associated with prostate cancer. Cancer Epidemiol Biomark Prev. 2009;18(9):2460–7. https://doi.org/10.1158/1055-9965.EPI-09-0058.
Barrow PJ, Ingham S, O'Hara C, Green K, McIntyre I, Lalloo F, et al. The spectrum of urological malignancy in Lynch syndrome. Fam Cancer. 2013;12(1):57–63. https://doi.org/10.1007/s10689-012-9573-z.
Ryan S, Jenkins MA, Win AK. Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis. Cancer Epidemiol Biomark Prev. 2014;23(3):437–49. https://doi.org/10.1158/1055-9965.epi-13-1165.
Win AK, Lindor NM, Jenkins MA. Risk of breast cancer in Lynch syndrome: a systematic review. Breast Cancer Res. 2013;15(2):R27. https://doi.org/10.1186/bcr3405.
Win AK, Lindor NM, Winship I, Tucker KM, Buchanan DD, Young JP, et al. Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst. 2013;105(4):274–9. https://doi.org/10.1093/jnci/djs525.
Win AK, Lindor NM, Young JP, Macrae FA, Young GP, Williamson E, et al. Risks of primary extracolonic cancers following colorectal cancer in Lynch syndrome. J Natl Cancer Inst. 2012;104(18):1363–72. https://doi.org/10.1093/jnci/djs351.
Win AK, Young JP, Lindor NM, Tucker KM, Ahnen DJ, Young GP, et al. Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol. 2012;30(9):958–64. https://doi.org/10.1200/JCO.2011.39.5590.
Elston RC, Stewart J. A general model for the genetic analysis of pedigree data. Hum Hered. 1971;21(6):523–42.
Lange K, Weeks D, Boehnke M. Programs for pedigree analysis: MENDEL, FISHER, and dGENE. Genet Epidemiol. 1988;5(6):471–2. https://doi.org/10.1002/gepi.1370050611.
Bonaiti B, Bonadona V, Perdry H, Andrieu N, Bonaiti-Pellie C. Estimating penetrance from multiple case families with predisposing mutations: extension of the ‘genotype-restricted likelihood’ (GRL) method. Eur J Hum Genet. 2011;19(2):173–9. https://doi.org/10.1038/ejhg.2010.158.
Carayol J, Bonaiti-Pellie C. Estimating penetrance from family data using a retrospective likelihood when ascertainment depends on genotype and age of onset. Genet Epidemiol. 2004;27(2):109–17. https://doi.org/10.1002/gepi.20007.
Antoniou AC, Pharoah PD, McMullan G, Day NE, Ponder BA, Easton D. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol. 2001;21(1):1–18. https://doi.org/10.1002/gepi.1014.
Gong G, Hannon N, Whittemore AS. Estimating gene penetrance from family data. Genet Epidemiol. 2010;34(4):373–81. https://doi.org/10.1002/gepi.20493.
Cannings C, Thompson EA, Skolnick MH. Probability functions on complex pedigrees. Adv Appl Probab. 1978;10(1):26–61. https://doi.org/10.2307/1426718.
Acknowledgement
The National Health and Medical Research Council, Australia, has supported this research via a project grant and via research fellowships. We thank all researchers, clinicians and genetic counsellors at participating centres who have given their time and resources and the Lynch syndrome families.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Jenkins, M.A., Reece, J.C., Win, A.K. (2018). The International Mismatch Repair Consortium. In: Valle, L., Gruber, S., Capellá, G. (eds) Hereditary Colorectal Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74259-5_30
Download citation
DOI: https://doi.org/10.1007/978-3-319-74259-5_30
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-74258-8
Online ISBN: 978-3-319-74259-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)